Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024
After years of manufacturing woes, Pfizer appeared to turn a corner earlier this year for its growing sterile injectables portfolio. But even with signs trending upward, Pfizer is preparing to exit an Australian site specializing in those drugs as part of a global reorganization effort.
Pfizer will walk away from its more than 50-year-old facility in Perth, Australia—and jeopardize 470 jobs—as the company undergoes a "thorough evaluation" of its global manufacturing chain, a Pfizer spokeswoman said Monday.
The New York-based drugmaker expects to wind down operations at the Perth site by the end of 2023 and fully exit the facility in the first quarter of 2024. The facility specializes in sterile injectable manufacturing and mostly supplies drugs to the Australian and New Zealand markets, according to Pfizer's website.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Just Now, Pfizer's Blockbuster Small Molecule New Drug Paxlovid was Urgently Approved in China!
-
The Final Effective Rate Of Pfizer's Oral New Covid Drug Is 89%
-
Pfizer and BioNTech achieve Health Canada authorization for their vaccine to com
-
Pfizer and BioNTech announce publication of results from landmark Phase 3 trial
-
FDA expert panel recommends EUA for Pfizer/BioNTech COVID-19 vaccine
-
European Commission approves contract with BioNTech-Pfizer alliance
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
A Rare Vote of Confidence: INEOS to Invest €250 Million in French Cracker Plant
-
Evonik Inaugurates New Speciality Alumina Plant in Japan, Bolstering Regional Growth Strategy
-
After Two Price Hikes in One Week, Dow Has Fully Exposed the Most Sensitive Nerve in Europe’s Polyurethane Market
Recommend Reading
-
![Wanhua Chemical’s “Tale of Two Cities”: 850,000 Tonnes Isn’t Capacity—It’s a Declaration of War]()
Wanhua Chemical’s “Tale of Two Cities”: 850,000 Tonnes Isn’t Capacity—It’s a Declaration of War
-
![BASF’s 2025 Report Card—“The Profit Evaporation Act”: Behind the €6.6 Billion EBITDA Lies a Deliberate Strategic Retreat]()
BASF’s 2025 Report Card—“The Profit Evaporation Act”: Behind the €6.6 Billion EBITDA Lies a Deliberate Strategic Retreat
-
![An Explosion Has Occurred in the Jubail Industrial City, Putting 6–8% of Global Petrochemical Production Capacity at Risk]()
An Explosion Has Occurred in the Jubail Industrial City, Putting 6–8% of Global Petrochemical Production Capacity at Risk
-
![“Hidden Champion” Swallowed Whole: PPG’s Acquisition of EMM Isn’t Just About Three Brands—It’s a Grab for the Next Decade’s Coating Authority]()
“Hidden Champion” Swallowed Whole: PPG’s Acquisition of EMM Isn’t Just About Three Brands—It’s a Grab for the Next Decade’s Coating Authority
-
![“Europe’s Chemical Industry Is Bleeding”: 37 Million Tons of Capacity Shut Down in 4 Years—Is the Industrial Heartbeat Failing?]()
“Europe’s Chemical Industry Is Bleeding”: 37 Million Tons of Capacity Shut Down in 4 Years—Is the Industrial Heartbeat Failing?
-
![Adequate Supply, PP Market Weak in Mid-November in China]()
Adequate Supply, PP Market Weak in Mid-November in China
-
![Business Society September 22, 2026 Petroleum Coke Trend Analysis: Volatility]()
Business Society September 22, 2026 Petroleum Coke Trend Analysis: Volatility
-
![Phosphate Market Shows Narrow Fluctuations (10.17-10.23)]()
Phosphate Market Shows Narrow Fluctuations (10.17-10.23)
-
![Business Society October 13, 2026 MTBE Trend Analysis: Strong Consolidation]()
Business Society October 13, 2026 MTBE Trend Analysis: Strong Consolidation
-
![China's Natural Rubber Market Narrowly Consolidates]()
China's Natural Rubber Market Narrowly Consolidates
